Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future
Published inClinical Pharmacology and Therapeutics, vol. 101, no. 5, p. 646-656
Publication date2017
Abstract
Keywords
- Cost-Benefit Analysis
- Delivery of Health Care
- Integrated
- Forecasting
- Humans
- Models
- Biological
- Pharmaceutical Preparations/administration & dosage
- Precision Medicine/trends
Citation (ISO format)
DARWICH, A S et al. Why has model-informed precision dosing not yet become common clinical reality? lessons from the past and a roadmap for the future. In: Clinical Pharmacology and Therapeutics, 2017, vol. 101, n° 5, p. 646–656. doi: 10.1002/cpt.659
Main files (1)
Article (Published version)
Identifiers
- PID : unige:98706
- DOI : 10.1002/cpt.659
- PMID : 28182269
Journal ISSN0009-9236